P0A460 AF NFT

Type II Methyl-directed restriction enzyme DpnI

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigdfwoq6a56jfxe6skvrwxzgifqqmkzkygisbeuu3uza6yl3jtkzu/metadata.json
IPFS of structure file: 
bafybeicp7zwdz4diatj32q6lqh5737e7svh77ipoplbfn4pyktmhm2uhja/AF-P0A460-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x272511D5F14E62CC0ef5f0eB6Ac2c4A390EfC88b
First NFT owner address (bech32): 
genesis1yuj3r403fe3vcrh47r4k4sky5wgwljytevg9vk
Current NFT ID #456334 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
456334
Accession (UniProt):
P0A460
Name::
Type II Methyl-directed restriction enzyme DpnI
Experimental Method:
Predicted structure
Sequence source:
STREPTOCOCCUS PNEUMONIAE (STRAIN ATCC BAA-255 / R6)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P0A460 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P0A460|T2D1_STRR6 Type II Methyl-directed restriction enzyme DpnI OS=Streptococcus pneumoniae (strain ATCC BAA-255 / R6) OX=171101 GN=dpnC PE=1 SV=1 MELHFNLELVETYKSNSQKARILTEDWVYRQSYCPNCGNNPLNHFENNRPVADFYCNHCSEEFELKSKKGNFSSTINDGAYATMMKRVQADNNPNFFFLTYTKNFEVNNFLVLPKQFVTPKSIIQRKPLAPTARRAGWIGCNIDLSQVPSKGRIFLVQDGQVRDPEKVTKEFKQGLFLRKSSLSSRGWTIEILNCIDKIEGSEFTLEDMYRFESDLKNIFVKNNHIKEKIRQQLQILRDKEIIEFKGRGKYRKL